| Product name | ZZZ3 Polyclonal Antibody |
| Immunogen | Synthesized peptide derived from the Internal region of human ZZZ3 at AA range: 310-390 |
| Host | Rabbit |
| Reactivity | Human,Mouse,Rat |
| Applications | WB,ELISA |
| Applications notes | Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000;ELISA 1:5000;Not yet tested in other applications. |
| Clonality | Polyclonal |
| Preparation method | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Alternative | ZZZ3; ZZ-type zinc finger-containing protein 3 |
| Formulation | Liquid solution |
| Concentration | 1 mg/ml |
| Molecular weight | 160kD |
| Storage buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Storage instructions | Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing. |
| Shipping | Gel pack with blue ice. |
| Precautions | The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product. |
| Background | Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4. |
| Gene ID | 26009 |
| Alternative | ZZZ3; ZZ-type zinc finger-containing protein 3 |
| Others | ZZZ3 Polyclonal Antibody detects endogenous levels of ZZZ3 protein. |
| Accession | Q8IYH5 |
| Observed Band(KD) | 102 |
Fig. Western Blot analysis of various cells using ZZZ3 Polyclonal Antibody. Secondary antibody (catalog#: A21020) was diluted at 1:20000.
You must be logged in to post a review.
Reviews
There are no reviews yet.